gaining weight after stopping tirzepatide Regain Tirzepatide: What Research Shows What really happens when patients

Researchers use this compound to investigate the combined molecular behaviors of its constituent peptides across tissue-related, immunological, and extracellular matrix signaling pathways

Am J Physiol 1990;259(4 Pt 1):G530-5

But patients are also reporting reduced desire for alcohol, cigarettes, gambling, and compulsive behaviours they were not prescribed the drug to treat

While Mounjaro is part of the bigger GLP-1 drug family, its actually a bit different from other medications that are GLP-1 agonists, like Ozempic and Wegovy

A decline in insulin dose requirement could explain weight reduction after intensification with the dual agonist in this setting

meta-analyses are hampered by heterogeneity and selective reporting